Keywords: miglitol, debuts, germany, sanofi, launched, alpha-glucosidase, inhibitor
Miglitol Debuts In Germany
Article | 18 June 1998
Sanofi has launched the alpha-glucosidase inhibitor Diastabol (miglitol)in its first market, Germany, for the management of patients with type 2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
